Evidence map›Paper›PMID 40191676›Full record

ArticleWorld journal of clinical cases2025

Systemic thrombosis with prothrombin Belgrade mutation in a Chinese patient: A case report.

Yan-Feng Wu, Yan Huang, Bao-Hui Weng, Shan Deng, Li-Ya Pan, Zhen Li

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan-Feng WuDepartment of Neurology, Liuzhou Worker's Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China.
Yan HuangDepartment of Neurology, Liuzhou Worker's Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China.
Bao-Hui WengDepartment of Neurology, Liuzhou Worker's Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China.
Shan DengDepartment of Neurology, Liuzhou Worker's Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China.
Li-Ya PanDepartment of Neurology, Liuzhou Worker's Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China.
Zhen LiDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China. lzz_tmu@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThrombophilia contributes to a significant increased risk of venous thromboembolism and can be either inherited or acquired. Hereditary thrombophilia may arise from various gene mutations, some of which have not even been adequately reported or poorly understood. Previous studies reported a rare and novel missense mutation in the prothrombin gene (p.Arg596Gln), known as prothrombin Belgrade. The mechanisms and therapeutic strategies associated with prothrombin Belgrade mutation have not been fully elucidated. CASE SUMMARY: We present the case of a 26-year-old woman with recurrent systemic thrombosis induced by prothrombin Belgrade mutation. The patient suffered from cerebral venous sinus thrombosis that rapidly progressed to systemic thrombosis, alongside a family history of cerebral thrombosis, and no traditional risk factors or abnormal coagulation function. Whole-genome sequencing detected a novel and rare heterozygous prothrombin missense mutation, c.1787G>T (p.Arg596Gln), which was responsible for the major etiology of the systemic thrombosis.

conclusionThis case strengthens our understanding about hereditary basis of thrombophilia and provokes considerations for therapeutic options on prothrombin Belgrade mutation.

Indexed as

Arg596GlnBelgrade mutationCase reportProthrombinThrombophilia

Identifiers

PMID40191676
PMCPMC11670033

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.